Nephrology https://www.bioworld.com/rss en-us Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment http://www.bioworld.com/articles/730930 Thu, 07 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/730930-circulating-sncrna-transcriptome-in-diabetic-kidney-disease-and-sglt2-inhibitor-treatment Ru@TiO2 protects kidneys from acute injury http://www.bioworld.com/articles/730348 Tue, 14 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730348-rutio2-protects-kidneys-from-acute-injury Kidney illustration Travere’s Filspari approved for rare kidney disease FSGS http://www.bioworld.com/articles/730293 Tue, 14 Apr 2026 08:00:00 -0400 https://www.bioworld.com/articles/730293-traveres-filspari-approved-for-rare-kidney-disease-fsgs Kidneys, pills and chart line PKU ballyhoo averting Street’s gaze from Maze phase II AMKD win? http://www.bioworld.com/articles/729839 Wed, 25 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729839-pku-ballyhoo-averting-streets-gaze-from-maze-phase-ii-amkd-win Kidney disease illustration Vertex filing BLA for ‘best-in-class’ IgAN drug on Rainier win http://www.bioworld.com/articles/729449 Tue, 10 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729449-vertex-filing-bla-for-best-in-class-igan-drug-on-rainier-win Kidneys GSK licenses Frontier Biotechnologies’ siRNA therapeutics http://www.bioworld.com/articles/729033 Wed, 25 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/729033-gsk-licenses-frontier-biotechnologies-sirna-therapeutics Illustration of kidney with DNA structures Asahi Kasei advances ETA receptor antagonist into clinic http://www.bioworld.com/articles/728935 Thu, 19 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728935-asahi-kasei-advances-eta-receptor-antagonist-into-clinic 3D illustration of kidney cross section NMPA clears Gensci-136 for trials in immunoglobulin A nephropathy http://www.bioworld.com/articles/728881 Mon, 16 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728881-nmpa-clears-gensci-136-for-trials-in-immunoglobulin-a-nephropathy Hands holding pink paper kidneys Salubris Pharma divulges new dual ETA/AT1 antagonists http://www.bioworld.com/articles/728844 Fri, 13 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728844-salubris-pharma-divulges-new-dual-eta-at1-antagonists CD206+ macrophage-targeting peptide alleviates obstructive renal fibrosis in mice http://www.bioworld.com/articles/728833 Fri, 13 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728833-cd206-macrophage-targeting-peptide-alleviates-obstructive-renal-fibrosis-in-mice Illustration of diseased kidney Chinese researchers discover new SLC22A12 inhibitors http://www.bioworld.com/articles/728796 Wed, 11 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728796-chinese-researchers-discover-new-slc22a12-inhibitors Paragonix’s Kidneyvault extends kidney preservation to 29 hours http://www.bioworld.com/articles/728660 Fri, 06 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728660-paragonixs-kidneyvault-extends-kidney-preservation-to-29-hours Paragonix KidneyVault Paragonix Technologies’ Kidneyvault portable renal perfusion system. Credit: Paragonix Technologies Inc. TGR5 as a target for acute kidney injury http://www.bioworld.com/articles/728606 Wed, 04 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728606-tgr5-as-a-target-for-acute-kidney-injury Kidneys University of Antwerp patent divulges ferroptosis inhibitors http://www.bioworld.com/articles/728518 Tue, 03 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728518-university-of-antwerp-patent-divulges-ferroptosis-inhibitors PGC-1α gene delivery protects against kidney reperfusion injury http://www.bioworld.com/articles/728299 Fri, 23 Jan 2026 08:00:00 -0500 https://www.bioworld.com/articles/728299-pgc-1-gene-delivery-protects-against-kidney-reperfusion-injury Illustration of kidneys floating over gloved hand Chinese scientists patent new CYP11B2 inhibitors http://www.bioworld.com/articles/728012 Thu, 15 Jan 2026 08:00:00 -0500 https://www.bioworld.com/articles/728012-chinese-scientists-patent-new-cyp11b2-inhibitors Series B financing at Mediar Therapeutics http://www.bioworld.com/articles/727743 Thu, 08 Jan 2026 08:00:00 -0500 https://www.bioworld.com/articles/727743-series-b-financing-at-mediar-therapeutics Doctor with illustration of kidneys Huayao Jiyuan (Shenzhen) Pharmaceutical discovers new HIF-2α inhibitors http://www.bioworld.com/articles/727494 Tue, 30 Dec 2025 08:00:00 -0500 https://www.bioworld.com/articles/727494-huayao-jiyuan-shenzhen-pharmaceutical-discovers-new-hif-2-inhibitors Rectify Pharmaceuticals and Boehringer Ingelheim partner in CKD http://www.bioworld.com/articles/727423 Tue, 23 Dec 2025 08:00:00 -0500 https://www.bioworld.com/articles/727423-rectify-pharmaceuticals-and-boehringer-ingelheim-partner-in-ckd Kidneys Inhibition of PDE1A halts progression of renal fibrosis in mice http://www.bioworld.com/articles/727263 Thu, 18 Dec 2025 08:00:00 -0500 https://www.bioworld.com/articles/727263-inhibition-of-pde1a-halts-progression-of-renal-fibrosis-in-mice Targeting WWP2 prevents progression of acute kidney injury http://www.bioworld.com/articles/727156 Tue, 16 Dec 2025 08:00:00 -0500 https://www.bioworld.com/articles/727156-targeting-wwp2-prevents-progression-of-acute-kidney-injury Illustration of kidneys floating over gloved hand Otsuka’s IgAN therapy gets a thumbs-up from the FDA http://www.bioworld.com/articles/726792 Tue, 02 Dec 2025 00:00:00 -0500 https://www.bioworld.com/articles/726792-otsukas-igan-therapy-gets-a-thumbs-up-from-the-fda Kidneys Q32 sells rare kidney disease drug to Akebia for $12M up front http://www.bioworld.com/articles/726603 Mon, 01 Dec 2025 12:00:00 -0500 https://www.bioworld.com/articles/726603-q32-sells-rare-kidney-disease-drug-to-akebia-for-12m-up-front Kidney disease illustration Eli Lilly divulges new RXFP1 agonists http://www.bioworld.com/articles/726661 Fri, 28 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726661-eli-lilly-divulges-new-rxfp1-agonists Otsuka’s IgAN therapy gets a thumbs-up from the FDA http://www.bioworld.com/articles/726713 Wed, 26 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726713-otsukas-igan-therapy-gets-a-thumbs-up-from-the-fda Kidneys ‘Encyclopedia’ of xenotransplantation reveals drivers of immune rejection Nature in two papers – one focusing on physiological and immunological measurements, the other on multiomics.]]> http://www.bioworld.com/articles/726373 Tue, 18 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726373-encyclopedia-of-xenotransplantation-reveals-drivers-of-immune-rejection Abstract illustration of pig and human with medical motifs ‘Most complete’ map of oral microbiome enables links to systemic disease Cell Host & Microbe on Nov. 12, 2025, the database is expected to serve as a universal platform for academia and enable “precision microbiome medicine” for the industry, Lee told BioWorld.]]> http://www.bioworld.com/articles/726351 Tue, 18 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726351-most-complete-map-of-oral-microbiome-enables-links-to-systemic-disease Microbiome illustration Credit: Darryl Leja, NHGRI Johns Hopkins reports work on gene therapy for ADPKD http://www.bioworld.com/articles/726081 Mon, 17 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726081-johns-hopkins-reports-work-on-gene-therapy-for-adpkd ‘Encyclopedia’ of xenotransplantation reveals drivers of immune rejection Nature in two papers – one focusing on physiological and immunological measurements, the other on multiomics.]]> http://www.bioworld.com/articles/726077 Mon, 17 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726077-encyclopedia-of-xenotransplantation-reveals-drivers-of-immune-rejection Abstract illustration of pig and human with medical motifs Gentibio’s GNTI-823 promotes renal repair in AKI models http://www.bioworld.com/articles/726032 Thu, 13 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726032-gentibios-gnti-823-promotes-renal-repair-in-aki-models